image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
7bb7637540cc0f23156786006e367ff679945286d3b3b03a5702d69853cee5c4.png | simple | <table><tr><td>Treatments</td><td>Species</td><td>Duration</td><td>Metabolic disorders</td><td>Potential mechanism</td><td>Reference</td></tr><tr><td>0–250 μmol/l capsaicin</td><td>3T3-L1 preadipocytes and adipocytes</td><td>24–72 h</td><td>Decreased the amount of intracellular triglycerides, GPDH acti... |
c6ef97b3f2db6fb67474085b8a5d2a7e2f6a0dcd763fd47d1468108018b6f0cb.png | complex | <table><tr><td>Themes</td><td>Subtheme</td><td>Item</td></tr><tr><td rowspan="9">LEADERSHIP/Governance</td><td>Systematic Approach</td><td>Giving no priority to the discharge planning in heath systemLack of comprehensive plan to develop discharge planning in the ministry of healthLack of patient-centered approach in th... |
1f51f68348099d86990c166eb9b58073ba902d1ed6327b32d8fbf1291bec2ea4.png | complex | <table><tr><td></td><td>Treatment</td><td>DF</td><td>F-value</td><td>P-value</td><td>R-square</td></tr><tr><td rowspan="3">Emergence Holes</td><td>Depth (D)</td><td>4</td><td>19.90</td><td><0.001</td><td rowspan="3">68.53</td></tr><tr><td>Volume (V)</td><td>2</td><td>83.25</td><td><0.001</td></tr><tr><td>Error</t... |
9bb7b0c4bcdcfcd2ec4630a922264660888e7afb20800717176c56a9486d862c.png | complex | <table><tr><td></td><td></td><td colspan="4">Mcm2 immunoreactivity</td></tr><tr><td>Variable</td><td>Categorisation</td><td>n analysable</td><td>negative (<40%)</td><td>positive (≥40%)</td><td>p<sup>a</sup></td></tr><tr><td colspan="6"><i>Clinico-pathologic data:</i></td></tr><tr><td colspan="6">Age at diagnos... |
6c99e7e0efdaeba8a0c23211b9ef0e5c22b1941d9525d0ea912676df2640243e.png | complex | <table><tr><td></td><td colspan="2">4-week exposure</td><td colspan="2">13-week exposure</td></tr><tr><td></td><td>Control</td><td>BaSO<sub>4</sub></td><td>Control</td><td>BaSO<sub>4</sub></td></tr><tr><td>BaSO<sub>4</sub> lung burden (mg)</td><td></td><td>0.84 ± 0.18</td><td></td><td>1.73 ± 0.85</td></tr><tr... |
8ade2678cfc7b5da86fa63a2b845ae395de9548ced3566148b1364670aeb3902.png | complex | <table><tr><td>Fibroblast</td><td>PD+/− rotenone (R)</td><td>Number of DEGs</td></tr><tr><td rowspan="4">MRC-5</td><td>PD38 − R to PD38 + R</td><td>1</td></tr><tr><td>PD42 − R to PD42 + R</td><td>2086</td></tr><tr><td>PD48 − R to PD48 + R</td><td>3527</td></tr><tr><td>PD52 − R to PD52 + R<... |
442cf6b6d5ee58201439c3b679cfed00f1121ef21daf01b04f858b43d01b9549.png | simple | <table><tr><td> Groups </td><td> AUC </td><td> Sens. </td><td> Spec. </td><td> Acc.</td></tr><tr><td> 0 versus 123 </td><td> 0.945 </td><td> 0.750 </td><td> 0.959 </td><td> 0.930</td></tr><tr><td> 01 versus 23 </td><td> 0.919 </td><td> 0.886 </td><td> 0.900 </td><td> 0.872</td></tr><tr><td> 012 versus 3 </td><td> 0.970... |
a212d6d7f2c979a8b29dbe74a3bf8c9900836be8c7dd0f5cf05ea09a3374f804.png | simple | <table><tr><td>Common name</td><td>Species</td><td>LTA</td><td>LTB</td></tr><tr><td>Deer mouse</td><td>Peromyscus maniculatus</td><td>AY251294</td><td>AY282503</td></tr><tr><td>House mouse</td><td><i>Mus musculus</i></td><td>NM_010735</td><td>MMU16984</td></tr><tr><td>Rat</td><td><i>Rattus norvegicus</i></td><td>NM_080... |
ecc28297625b78279cccf66845bb845c4406cebba12cdecd3d02c18e4b516641.png | simple | <table><tr><td>miRNA</td><td>Regulation [17]</td><td>Potential regulation mechanism [17, 18]</td><td>Class [17]</td></tr><tr><td>miR-9-5p</td><td>Up</td><td>Chromosomal gain (1q)</td><td>Late</td></tr><tr><td>miR-15b-5p</td><td>Up</td><td>Chromosomal gain (3q)</td><td>Late</td></tr><tr><td>miR-28-5p</td><td>Up</td><td>... |
2a03e4d5656225c5760b05f646cf0ad95496549d352544d36f57781ec0f665a8.png | complex | <table><tr><td> </td><td colspan="8">Period of time</td><td>Significant difference between quarters</td></tr><tr><td> </td><td colspan="2">Quarter 1</td><td colspan="2">Quarter 2</td><td colspan="2">Quarter 3</td><td colspan="2">Quarter 4</td><td> </td></tr><tr><td>Cost category</td><td>Means</td><td>(SD)</td><td>Means... |
17d5dcb1a24fed8a7c7236f488e89d1b37937620ec521d991ead9873d0e75fc3.png | simple | <table><tr><td>Animal</td><td>Skin non-midge fed**</td><td>Skin midge fed***</td><td>Tonsil</td><td>Lips</td><td>Lung</td></tr><tr><td>Sheep VH56/ 3 dpi</td><td>Minor engorgement, with indistinct vacuolation of epidermal cells.</td><td>Mildly oedematous/focal epidermal crusts/mild dermal inflammation *(lymphocytes, pla... |
36f3056e81180c7927e9c1834545ca05b1bd77acad7dc4065e1ad52d797a1d64.png | complex | <table><tr><td rowspan="2">Age category, y</td><td colspan="3"><i>BRCA1</i> carriers</td><td colspan="3"><i>BRCA2</i> carriers</td></tr><tr><td>No. of events</td><td>HR per unit SD increase in the ER- PRS (95% CI)</td><td><i>P</i>†</td><td>No. of events</td><td>HR per unit SD increase in the overall BC PRS (95% C... |
cb8ce80fc6149d3c9af03f52f0bb3075778b8a28e18324e6bfee084838b8cb02.png | simple | <table><tr><td></td><td>Controls</td><td>Pre-RA</td><td>Univariate</td><td></td><td>Multivariate</td><td></td></tr><tr><td></td><td></td><td></td><td>OR (95 % CI)</td><td><i>p</i>-value</td><td>OR (95 % CI)<sup>a</sup></td><td><i>p</i>-value</td></tr><tr><td>Intensity, n (%)</td><td></td><td></td><td></td><td></td><td>... |
d95491750e89eae0ba421c4533e5feedbd50442815562cd940e410acefaeb4df.png | simple | <table><tr><td>Attribute</td><td>Number (%)</td></tr><tr><td>Age</td><td> </td></tr><tr><td>Mean Age</td><td>40.6 years</td></tr><tr><td>Standard deviation</td><td>9.1 years</td></tr><tr><td>Marital status (N = 220)</td><td> </td></tr><tr><td>Married</td><td>229 (71.5)</td></tr><tr><td>Single</td><td>45 (14.1)</td></tr... |
07f0d59bf1586887f4a8d6ba37552e42016731699e2b5fb5657a68b0f92a276a.png | complex | <table><tr><td>Category</td><td>Frequency</td><td>%</td></tr><tr><td><i>Gender</i></td><td> </td><td> </td></tr><tr><td>Female</td><td>91</td><td>49.2</td></tr><tr><td>Male</td><td>94</td><td>50.8</td></tr><tr><td colspan="3"> </td></tr><tr><td><i>Age</i></td><td> </td><td> </td></tr><tr><td>≤6 months</td><td>8</... |
403b93c70ee211b2bcf62a2a981aecc26e2885c046e932d2e8d16753e7d669c3.png | simple | <table><tr><td>gene</td><td>forward primer</td><td>reverse primer</td><td>probe</td></tr><tr><td>HPRT</td><td><i>5′-tgaacgtcttgctcgagatgtg-3′</i></td><td><i>5′-ccagcaggtcagcaaagaattt-3′</i></td><td><i>5′-tgggaggccatcacattgtagcc-3′</i></td></tr><tr><td>SNCA</td><td><i>5′-ccaaaga... |
75cd19ce06927091ed2972261731e2137eec86d94a2dc274f9492afae0f5b3d8.png | simple | <table><tr><td>Property</td><td>Water</td><td>Blood</td><td>Units</td></tr><tr><td>Density <i>ρ</i></td><td>1000</td><td>1050 [25]</td><td>kg/m<sup>3</sup></td></tr><tr><td>Specific heat <i>c</i></td><td>4190 [26]</td><td>3850 [25]</td><td>J/(kg · K)</td></tr><tr><td>Thermal conductivity <i>k</i></td><td>0.61... |
41e8e737c3c2d8586fb842dd88a878468e40c62c5525fe2fc04eba7482b5e129.png | simple | <table><tr><td>Source</td><td>df</td><td>SS</td><td>MS</td><td>Est. Var.</td><td>%</td></tr><tr><td>Among Pops</td><td>10</td><td>164.219</td><td>16.422</td><td>0.628</td><td>12%</td></tr><tr><td>Among Indiv</td><td>66</td><td>528.158</td><td>8.002</td><td>3.443</td><td>66%</td></tr><tr><td>Within Indiv</td><td>74</td>... |
65155ce47de619697536edb74f2ecf0acd75ea354ebc7ec8113da3fd48d472af.png | complex | <table><tr><td></td><td colspan="2"><i>Un-adjusted HRs (95% C.I.)</i></td><td colspan="2"><i>Adjusted</i><sup><i>a </i></sup><i>HRs (95% C.I.)</i></td></tr><tr><td><i>LNs extracted</i></td><td><i>Stage II</i></td><td><i>Stage III</i></td><td><i>Stage II</i></td><td><i>Stage III</i></td></tr><tr><td><underline>5 Years D... |
a6e8860ed712cfa4b2a08c6aeb01c4125584132076bc22a99bcf39cd33ba7408.png | simple | <table><tr><td> </td><td>Total (n = 1,304)</td><td>NSV (n = 806)</td><td>Rape (n = 183)</td><td>NCS (n = 315)</td><td>OR RAPE/NSV</td><td>OR NCS/NSV</td><td>OR Rape/NCS</td><td><i>χ</i><sup><i>2</i></sup><i>/F</i><sup>†</sup></td></tr><tr><td>Have been separated from family</td><td>284 (22.1%)</td><td>137 (1... |
cdf13183f63b9b3bab1f52e69270b83073d111ab328e16ec3a49849e8389ed08.png | complex | <table><tr><td></td><td colspan="5">Screening or Intervention (Dependent Variable)</td></tr><tr><td></td><td>Asked about AOD use</td><td>Suggested cutting down or stopping AOD use</td><td>Referred for specialty care</td><td>Counseled for > = 5 min</td><td>Asked and provided any treatment</td></tr><tr><td>Independent... |
28038510ca983c364308fa41017f319c45fa0da2881343d8ba4f742752a645b8.png | simple | <table><tr><td>Rank</td><td>Feature description</td></tr><tr><td>1</td><td>Cumulative number of <i>30-day readmissions</i></td></tr><tr><td>2</td><td>Presence of <i>acute respiratory failure</i> ICD-9 code</td></tr><tr><td>3</td><td>Number of <i>abnormal sodium level</i> laboratory tests</td></tr><tr><td>4</td><td>Pres... |
14f140b50063417e99b361fb12576a07bcde169acbd48a093629a3286191be1c.png | simple | <table><tr><td>Location</td><td>Number</td></tr><tr><td>Spleen</td><td>14</td></tr><tr><td>Liver</td><td>13</td></tr><tr><td>Kidney</td><td>2</td></tr><tr><td>Diaphragm</td><td>2</td></tr><tr><td>Pancreas</td><td>2</td></tr></table> |
abd5661fc03f71373edd487ee3539ec4afbaa43274e21ea7febc6635be8fc838.png | complex | <table><tr><td rowspan="2">Measure</td><td colspan="4">Whole sample</td><td colspan="4">Males</td><td colspan="4">Females</td><td colspan="2">Mean difference (male–female)</td></tr><tr><td><i>N</i></td><td>Range</td><td>Mean</td><td>SD</td><td><i>N</i></td><td>Range</td><td>Mean</td><td>SD</td><td><i>N</i></td><t... |
753ac1208bfa11b3518f71b03f8441cfe524387a24dddbdcc3d2c40c27c5c926.png | complex | <table><tr><td rowspan="2">Tap</td><td colspan="2">Channel A</td><td colspan="2">Channel B</td><td>Doppler</td></tr><tr><td>Relative Delay (ns)</td><td>Average Power (dB)</td><td>Relative Delay (ns)</td><td>Average Power (dB)</td><td>Spectrum</td></tr><tr><td>1</td><td>0</td><td>0.0</td><td>0</td><td>–2.5</td><td... |
d1f28466d378f146c3bc37971c356badbcf5c69a95cb719efd6e194a42f6664c.png | simple | <table><tr><td> </td><td>Invasive fungal rhinosinusitis with orbital complications (<i>n</i> = 35)</td><td>Bacterial rhinosinusitis with orbital complications (<i>n</i> = 65)</td><td>Adjusted odds ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>Nasal crust</td><td>14</td><td>1</td><td>77.78 (1.95–3095.00)<... |
7e3e579d0cbfffcdbc81f409ee0ec5e8bee85d191ae243949ac937e896d91694.png | simple | <table><tr><td>Group</td><td>(1a) Ultramutated <i>POLE</i> mutant</td><td>(1b) Hypermutated dMMR/MSI</td><td>(2) CIN/SCNA-high, MSS</td></tr><tr><td>Mutation rate</td><td>++++</td><td>+++</td><td>+</td></tr><tr><td>Somatic copy number alterations</td><td>+/−</td><td>+</td><td>+++</td></tr><tr><td>Key molecular/ge... |
60409a6c747c4f6fb540b553c93c9c50d1041c4c0fe08327c9792ae63379b1cc.png | complex | <table><tr><td></td><td colspan="4"><i>N</i><sub>0</sub><i>S</i><sub>0</sub></td><td colspan="4"><i>N</i><sub>0</sub><i>S</i><sub>π</sub></td></tr><tr><td></td><td>HH</td><td>LL</td><td>LH</td><td>HL</td><td>HH</td><td>LL</td><td>LH</td><td>HL</td></tr><tr><td>Obs. 1</td><td>Limited<sup>**</sup></td><td></td><td><... |
221b3da9e5cb348697d57c9fac38be5bf988ef4562eaea777a5b929930907117.png | complex | <table><tr><td>Regimens of first-line chemotherapy</td><td>Overall</td><td colspan="2">MTB or MK infection</td></tr><tr><td></td><td></td><td>(+)</td><td>(–)</td></tr><tr><td></td><td>N = 30</td><td>N = 7</td><td>N = 23</td></tr><tr><td>Intensive regimens</td><td>26</td><td>6</td><td>20</td></tr><tr><td> FOLFOX</... |
16b96a4e44db1aeaad23a92d850fb7454870e6bf92342ab55f032e7a36dd9d6f.png | complex | <table><tr><td rowspan="2">Days</td><td colspan="4">Body weight (g)</td></tr><tr><td>N30 (100 mg/kg)</td><td>N30 (50 mg/kg)</td><td>Solvent control</td><td>Control</td></tr><tr><td>0</td><td>17.0 ± 1.1</td><td>17.0 ± 1.3</td><td>16.0 ± 0.9</td><td>15.9 ± 0.7</td></tr><tr><td>5</td><td>23.7 ± 0.... |
dd413b34451d96e41b227e96434f37b228eed4f4fe2ebee94fcc2b93e8f9e8ef.png | complex | <table><tr><td colspan="5">Activity against the Isolates</td></tr><tr><td rowspan="2">Antibiotics</td><td rowspan="2">Resistance Prevalence (%)</td><td colspan="3">MIC (mg L<sup>−1</sup>)</td></tr><tr><td>Range</td><td>50%</td><td>90%</td></tr><tr><td>Ampicillin (AMP)</td><td>100.0</td><td>64 to ≥1024</td><... |
a454960f6b3ff022af55b951c977c7755a7ad250fd0dbc6eaa2df157e439a97b.png | complex | <table><tr><td></td><td>Cases (n = 830)</td><td>Controls (n = 907)</td><td>P</td></tr><tr><td>Age*</td><td>43 (39–47)</td><td>41 (36–44)</td><td><0.001</td></tr><tr><td>Female</td><td>354 (43%)</td><td>407 (45%)</td><td>0.421</td></tr><tr><td>Black</td><td>353 (43%)</td><td>354 (39%)</td><td>0.207</td></... |
729fab2eca04a494ae3085d0ddd4e05a17c379ee43a444eed413184f30372909.png | complex | <table><tr><td rowspan="2">Characteristics, n (%)</td><td>Participants completing the SF-6D</td><td>Participants completing the EQ-5D-3L</td></tr><tr><td>(N = 1021)</td><td>(N = 1015)</td></tr><tr><td>Female</td><td>521 (51.0)</td><td>512 (50.4)</td></tr><tr><td>Age (years)</td><td></td><td></td></tr><tr><td> 21-29</td... |
13a29c9af5a704394e34d37d9de45de8fde60562d85c0cf3193e0a4d01bc39d5.png | simple | <table><tr><td>Study</td><td>Year</td><td><i>N</i></td><td>Criteria</td><td>Treatment</td><td>Findings</td></tr><tr><td>Hu et al. [6]</td><td>2006</td><td>84</td><td>Solitary brain metastasis</td><td>SRS or surgery</td><td>Stage I intrathoracic patients had better OS outcomes than stage III</td></tr><tr><td>Bonnette et... |
f7a757bc38771052098f0047c57af62d41986a61a9b7ff56ac401fc3b27ecd15.png | complex | <table><tr><td></td><td colspan="6">Average weekly doses (IU/kg)</td></tr><tr><td>Population by</td><td colspan="3">Weeks 12–24</td><td colspan="3">Weeks 37–52</td></tr><tr><td>Frequency of administration</td><td>n (%)</td><td>Mean ± SD</td><td>Median (Range)</td><td>n (%)</td><td>Mean ± SD</td><t... |
639ab3402bb89d3da3862277251632a5ff0ed2e21fc23cd02b2149fc6c3820f2.png | complex | <table><tr><td>Spot no</td><td>Fold difference</td><td colspan="2">Average normalized volumes</td></tr><tr><td></td><td></td><td>HF</td><td>KF</td></tr><tr><td>102</td><td>4.9</td><td>1.474</td><td>0.301</td></tr><tr><td>94</td><td>10.1</td><td>0.337</td><td>3.404</td></tr><tr><td>101</td><td>26.7</td><td>0.121</td><td... |
96fb93493d85efa67820fa633499427bbafba926bdc033848950689859aad201.png | simple | <table><tr><td></td><td>Diabetic (<i>N</i> = 8)</td><td>Non-diabetic (<i>N</i> = 60)</td><td><i>p</i> value</td></tr><tr><td>Days till admission, median (range)</td><td>4 (0–49)</td><td>15 (0–49)</td><td>0.367</td></tr><tr><td>Referral, No (%)</td><td></td><td></td><td>0.088</td></tr><tr><td> Admission to h... |
feeac364f01495fcb9f4651f63409117fd05d539deeb61078e1c130645ecd815.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td><i>p</i>-value</td><td>OR (95% CI)</td><td><i>p</i>-value</td><td>OR (95% CI)</td></tr><tr><td>Age</td><td>0.011*</td><td>1.038 (1.008 ~ 1.068)</td><td>0.004*</td><td>1.048 (1.015 ~ 1.081)</td>... |
401a61d0feb2513d5e2fd2a76fe201eef49061994571cc99ef17e4d9d9692f83.png | simple | <table><tr><td>Angiographic result</td><td>Total (<i>n</i> = 108) (%)</td><td>Anterior circulation (<i>n</i> = 92) (%)</td><td>Posterior circulation (<i>n</i> = 16) (%)</td></tr><tr><td>mTICI 0</td><td>8 (7.4)</td><td>4 (4.4)</td><td>4 (25)</td></tr><tr><td>mTICI 1</td><td>8 (7.4)</td><td>7 (7.6)</td><td>1 (6.3)</td></... |
02834ddfdf1fdccb9c880778e9df4add454e48c3a009adcba73b6210f61ae363.png | simple | <table><tr><td>Method</td><td>Phen. allowed <sup>a</sup></td><td>Input values <sup>b</sup></td><td><i>K</i><sup>c</sup></td><td>Link</td></tr><tr><td>Ref-based</td><td>Any</td><td>Beta</td><td>N/A</td><td>http://people.oregonstate.edu/~housemae/software/TutorialLondon2014</td></tr><tr><td></td><td></td><td></td><td></t... |
35956cb7ef0639e4b58d6b4642b79608e0dc200c5f0faec47a85524cbf4be130.png | complex | <table><tr><td></td><td colspan="4">Waiting List v Community</td><td colspan="3">Comparison of Means</td><td></td><td colspan="3">ROC</td><td colspan="4">Absolute Performance Gain</td></tr><tr><td>Instruments</td><td colspan="2">Community (n = 111)</td><td colspan="2">OWL(n = 45)</td><td>Effect size #</td><td>SD.</td><... |
c5fb5efd86ad1601df2b605f8de6d98bf7b34d6354e2b810d4ed16f505024709.png | complex | <table><tr><td>Material</td><td>Fixation method</td><td>Approximate global size (mm)</td><td>Maximum deviation factor</td><td>Minimum size factor</td><td>Number of elements</td></tr><tr><td>Cement</td><td>—</td><td>2.0</td><td>0.02</td><td>0.1</td><td>107556</td></tr><tr><td>Femoral prosthesis</td><td>—</td... |
23c5252524d2f38184d82e56204eeef91393f735957e150eb8a4fb5703604ebc.png | simple | <table><tr><td>Facies type</td><td>Model</td><td>Nugget</td><td>Partial sill</td><td>Range (m)</td></tr><tr><td>Sand flats</td><td>Exponential</td><td>0.103</td><td>0.223</td><td>3015</td></tr><tr><td>Mixed flats</td><td>Spherical</td><td>0.186</td><td>0.065</td><td>1029</td></tr><tr><td>Mud flats</td><td>Spherical</td... |
7dcb7728baf9aad94fffea14562b7373990eb5382b3e2f49866ab8d6bbc35d1d.png | simple | <table><tr><td>Variable</td><td>ACS,</td><td>No ACS,</td></tr><tr><td></td><td><i>N </i>= 128 (%)</td><td><i>N </i>= 790 (%)</td></tr><tr><td>Age (years) (mean; SD)</td><td>(56.2; 12.0)</td><td>(61.4; 12.2)</td></tr><tr><td>Male gender</td><td>78 (60.9)</td><td>362 (45.8)</td></tr><tr><td>Prior disease</td><td>60 (46.8... |
84666483f0554c459663bcfe3bd821e9570a9544a0f7e168082598ebc5e95593.png | simple | <table><tr><td>GCA Classification Criteria</td></tr><tr><td>(1) Age at onset ≥50 years</td></tr><tr><td>(2) A new headache</td></tr><tr><td>(3) Temporal artery abnormality such as tenderness to palpation or decreased pulsation</td></tr><tr><td>(4) Erythrocyte sedimentation rate ≥50 mm/h</td></tr><tr><td>(5)... |
df30313b621c5a954c75147e7a93c34d23e438d181b505447907e2c326f30cb1.png | simple | <table><tr><td>Items</td><td>Issues</td></tr><tr><td>Model units</td><td>• Headcounts do not reflect variation in effective workforce.• FTE measured in working hours can translate into a variable effective workforce.• FTE defined in reference to the most active physician category makes the assumption ... |
5364dd20656d6d9dafd0e6c0358a56c1e3247e32a766b72ee059bedc0a73c6e7.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Control</td><td rowspan="2">Laser 0.5</td><td rowspan="2">Laser 1.0</td><td colspan="3">p value*</td></tr><tr><td>Control <i>versus</i> 0.5</td><td>Control <i>versus</i> 1.0</td><td>0.5 <i>versus</i> 1.0</td></tr><tr><td>T0</td><td>0.8±0.3 100%</td><td>0.8±0.3 1... |
9a5f59dded4d63203ef315924229237167136306b4aeb7d1463a40380bfd2288.png | complex | <table><tr><td>Variable</td><td><i>N</i></td><td>%</td></tr><tr><td colspan="3">Age in years (<i>n</i> = 1533)</td></tr><tr><td> 15–19</td><td>15</td><td>1</td></tr><tr><td> 20–29</td><td>455</td><td>29.7</td></tr><tr><td> 30–39</td><td>710</td><td>46.3</td></tr><tr><td> 40–49</td><td>242</td><t... |
7a0ad4dca058991639e827f0ba0da8e5a8a6d397ac3edb85ca0d0a8d16a64245.png | complex | <table><tr><td>Category</td><td>Subcategory</td><td>Cases</td><td colspan="2">Monocytes(/mm<sup>3</sup>)</td><td>P value</td></tr><tr><td></td><td></td><td></td><td><545</td><td>≥545</td><td></td></tr><tr><td>Gender</td><td>Male</td><td>310</td><td>115</td><td>195</td><td>0.102</td></tr><tr><td></td><td>Female... |
28db50cbc5213f793dbaeb8544593541f5b45dd1819587df15f36ee74364d0cf.png | complex | <table><tr><td>Collection time</td><td>AKI (renal replacement)</td><td>Mean</td><td>Std</td><td>p-value</td></tr><tr><td rowspan="2">T1 preoperative</td><td>No</td><td>1,0</td><td>,27</td><td rowspan="2">0,06</td></tr><tr><td>Yes</td><td>1,24</td><td>,43</td></tr><tr><td rowspan="2">T2 start CBP</td><td>No</td><td>,80<... |
8c93f57dbe550c7340e762aed892e7e90829fa26c895d24e781aa2f59411f0db.png | complex | <table><tr><td rowspan="2">Model</td><td>Standardized coefficients</td><td rowspan="2">t</td><td rowspan="2">Sig.</td><td colspan="2">95.0 % confidence interval for B</td></tr><tr><td>Beta</td><td>Lower bound</td><td>Upper bound</td></tr><tr><td>(Constant)</td><td></td><td>−12.353</td><td><0.001</td><td>−... |
138de02958ea49d55736c39b6f8f171e649134b3bf790cbc8034359997ee9282.png | complex | <table><tr><td>Phytochemical</td><td>Name of the tests</td><td>Observed changes</td><td>Result</td></tr><tr><td rowspan="5">Alkaloids</td><td>Mayer's test</td><td>Creamy white precipitate</td><td>−</td></tr><tr><td>Hager's test</td><td>Yellow crystalline precipitate</td><td> +</td></tr><tr><td>Wagner's test</td><... |
605c8918667bb688a51842ee5a12b8795b56e4be8da64ec39d63044946dee48f.png | simple | <table><tr><td></td><td>Dynesys group (<i>n</i> = 95)</td><td>PLIF group (<i>n</i> = 81)</td><td><i>p</i></td></tr><tr><td>ODI (%)<sup>a</sup></td><td></td><td></td><td></td></tr><tr><td>Pre op</td><td>57.1 ± 7.7</td><td>56.1 ± 8.1</td><td>0.391</td></tr><tr><td>Mid-term</td><td>33.5 ± 6.6</td><td>33.9 &... |
e1356c98cd5582097d35164c3cb6cc782c7e5f2f529e05e34151b700cfd1b218.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Morning Snack</td><td colspan="3">Lunch</td><td colspan="3">Afternoon Snack</td><td></td><td></td><td></td></tr><tr><td>Na (mg)</td><td>Na density (mg/MJ)</td><td>Energy (kJ)</td><td>Na (mg)</td><td>Na Density (mg/MJ)</td><td>Energy (kJ)</td><td>Na (mg)</td><td>Na Density... |
8f7f13b39596cbd9d15fec8f15e8dea5c062b342d4302f52d946270114c31452.png | simple | <table><tr><td>Analyte</td><td>RT (min)</td><td>[M − H]<sup>−</sup> (<i>m/z</i>)</td><td>MS<sup><i>n</i></sup> (<i>m/z</i>)</td></tr><tr><td>Paeoniflorin sulfonate (12)</td><td>2.18</td><td>543.11</td><td>121.02</td></tr><tr><td>Albiflorin (2)</td><td>3.67</td><td>525.16</td><td>121.02</td></tr><tr><td>Paeo... |
311d76a459f2209b0837adfeac431260859846887d8f19c491b26e6db057e4da.png | simple | <table><tr><td>Strength of interaction</td><td>Definition</td></tr><tr><td>Strong</td><td>A strong inhibitor for a specific CYP is defined as an inhibitor that increases the AUC of a substrate for that CYP by equal to or more than 5-fold (or >80% decrease in clearance)</td></tr><tr><td>Moderate</td><td>A moderate in... |
ace93f5780b903de8805c8b32e7fa08b6f0fde442ecbf6ccc8f8e33d8b4df079.png | simple | <table><tr><td>Annotation category</td><td>Resource</td><td>Comments</td></tr><tr><td>Genomic</td><td>GENCODE</td><td>Variant classification and mapping to gene</td></tr><tr><td></td><td>Human DNA Repair Genes</td><td>Curated list from [40]</td></tr><tr><td>Protein</td><td>UniProt</td><td>Protein-specific annotation</t... |
9d835b69ed0dd71b599cc8e3a880a4544163419d2464e3724101fc092969f837.png | simple | <table><tr><td>Country</td><td>Sample Size SpA</td><td>Sample Size (Control)</td><td>Prevalence in Population</td><td>Prevalence in SpA</td><td>Prevalence in AS</td><td>OR AS/GP [95% CI]</td><td>Reference</td></tr><tr><td>Algeria</td><td>129 AS (ESSG and NY)</td><td>76 healthy blood donors</td><td>4%</td><td></td><td>6... |
25fbafa7aab0ca046a620ff674d7c99028a124bb2fd863fa9d052c97271db2fe.png | simple | <table><tr><td>Covariate</td><td>Relative risk</td><td>95 % CI</td><td><i>p</i> value</td></tr><tr><td>p62</td><td>0.764</td><td>NS</td><td>0.619</td></tr><tr><td>Histological grading</td><td>1.239</td><td>NS</td><td>0.392</td></tr><tr><td>Lymph node metastases</td><td>0.794</td><td>NS</td><td>0.510</td></tr><tr><td>Tu... |
0ff1c446ef4e99c8d57c9d329c41b8315579e3f477ca5a2eb1de1d5b37be274f.png | complex | <table><tr><td rowspan="2" colspan="2">Variables</td><td colspan="2">Syphilis</td><td>COR (95% CI)</td><td>AOR (95%CI)</td><td><i>P</i>-value</td></tr><tr><td>NR(<i>n</i> = 469)</td><td>R(<i>n</i> = 25)</td><td></td><td></td><td></td></tr><tr><td rowspan="3">Age(years)</td><td>< 25</td><td>155 (96.3)</td><td>6 (3.7)... |
f7db46a540812ae6b628ea46d7b8235bec6d9f85bf93c4fb242d87dbc241af09.png | simple | <table><tr><td>Food</td><td>GI</td></tr><tr><td>Gluten-free bread</td><td>230</td></tr><tr><td>Gluten-free pasta</td><td>255</td></tr><tr><td>Quinoa</td><td>186</td></tr></table> |
cc42fd8d2f14155004e1695a022667621a3d9a385385268ac74617ac9969d822.png | simple | <table><tr><td>Laccase Isoform</td><td>Experimental Affinity Rank <sup>1</sup></td><td>HINT Score</td></tr><tr><td>Beta</td><td>1</td><td>430</td></tr><tr><td>Gamma</td><td>2</td><td>206</td></tr><tr><td>Delta</td><td>3</td><td>104</td></tr></table> |
e5cfc6b029dc6208c9ca75c38c420660607fe0916f97ab5ee516bc7a7e090cde.png | complex | <table><tr><td>Variables</td><td>Number</td><td>All</td><td>Fish</td><td>Meat</td><td>Supplement</td><td><i>P</i><sup><i>a</i></sup></td></tr><tr><td colspan="7">Characteristics</td></tr><tr><td>Gender n (%)</td><td>415</td><td></td><td></td><td></td><td></td><td>0.546</td></tr><tr><td> Male</td><td></td><td>195 (47.0)... |
b2430183fc12c24991569c9f7b70293262dff2de5d309b85ae40c66966cd4b44.png | complex | <table><tr><td></td><td colspan="3">Screening set</td><td colspan="3">Validation set</td><td colspan="3">Merge set</td></tr><tr><td>SNP</td><td>Controls (<i>n</i> = 100)</td><td>LCs (<i>n</i> = 100)</td><td>OR (95% CI/<i>P</i><sub>trend</sub>)<sup>a</sup></td><td>Controls (<i>n</i> = 751)</td><td>LCs (<i>n</i> = 284)</... |
699b288b7d78103c5d2f907d114a0cb9adcf5d4d89ef4448222d36bed0cc618c.png | simple | <table><tr><td>Microorganisms</td><td>PN-EO</td><td>CHD<sup>a</sup></td><td>1<sup>b</sup></td><td>2<sup>b</sup></td><td>3<sup>b</sup></td><td>4<sup>b</sup></td><td>1 + 2 + 3 + 4<sup>c</sup></td></tr><tr><td><i>E. faecalis </i></td><td>250.0</td><td>14.8</td><td>>4000</td><td>>4000</td><td>>4000</td><td>>400... |
c2d2d423ea4f53563763187f5136e82bc26366325d7e7d789758b81e7930689c.png | simple | <table><tr><td>Isolates</td><td>Body site</td><td><i>spa</i> type</td><td>SCC<i>mec</i></td><td>ST<sup>a</sup></td><td>PFT<sup>b</sup></td></tr><tr><td>27 N</td><td>nasal</td><td>t002</td><td>II</td><td>ST105</td><td>A1</td></tr><tr><td>08 N</td><td>nasal</td><td>t311</td><td>II</td><td>ST105</td><td>B1</td></tr><tr><t... |
747fbc8b1e0e0b6ede078df6879c0289d2c3bcfe7abd9e98c049eac4683f7178.png | simple | <table><tr><td>Year</td><td>Trade Specialization Index (TSI)</td></tr><tr><td>2001</td><td>-0.940</td></tr><tr><td>2006</td><td>-0.898</td></tr><tr><td>2010</td><td>-0.844</td></tr></table> |
e8a0b04e86da95995bbaea3872a73b48911ba3a00fced139fb87a6e5fd0b7550.png | complex | <table><tr><td rowspan="2">Features </td><td colspan="3"> DNA configurations </td></tr><tr><td> A </td><td> B </td><td> Z </td></tr><tr><td>Helix orientation </td><td> Right-handed </td><td>Right-handed </td><td>Left-handed</td></tr><tr><td>DNA diameter </td><td> 2.55 </td><td> 2.37 </td><td> 1.84</td></tr><tr><td>bp d... |
02cca9587f84d174fe4d9e3d87c47f28c6f180c420871357250888f766dff9e2.png | simple | <table><tr><td>GOLD stage *</td><td>Number of patients (%)</td></tr><tr><td>Stage I</td><td>18 (17.0%)</td></tr><tr><td>Stage II</td><td>42 (39.6%)</td></tr><tr><td>Stage III</td><td>28 (26.4%)</td></tr><tr><td>Stage IV</td><td>18 (17.0%)</td></tr><tr><td>Total LAA score <sup>†</sup></td><td>Patient number (%)</t... |
db404ddfc2c4d9545d1c7d5b2755850208955814b9584cb2bb9ff8f9d153735a.png | complex | <table><tr><td>Kano Model</td><td colspan="2">Refined Kano Model</td></tr><tr><td>Quality Attribute</td><td>High Important Attributes</td><td>Low Important Attribute</td></tr><tr><td>Attractive quality</td><td>High attractive quality</td><td>Low attractive quality</td></tr><tr><td>One-dimensional quality</td><td>High v... |
c7409ca474048d95fd821fbcb39e1003c34188ba916c029dfce624c5b2acd353.png | complex | <table><tr><td>Molecule</td><td>Actions/effects</td><td>Reference</td></tr><tr><td rowspan="5">Sulfur dioxide</td><td>Possible long-term cardiac abnormality</td><td>Pishgoo et al. (15)</td></tr><tr><td>Cardiac and mitochondrial dysfunction (rats)</td><td>Qin et al. (1)</td></tr><tr><td>Increase heart susceptibility to ... |
0483e9140e3401aaa08d8c21b866db3b25da6de8c2bedd6ff0e35c9fafa23158.png | complex | <table><tr><td></td><td colspan="2">ST use</td><td></td><td></td><td colspan="4">RR/OR</td></tr><tr><td>Source<sup>a</sup></td><td>Type<sup>b</sup></td><td>Exposure<sup>c</sup></td><td>Smoking</td><td>Sex</td><td>Id.</td><td>Cases<sup>d</sup></td><td>Estimate (95%CI)</td><td>Adjustment factors<sup>e</sup></td></tr><tr>... |
fbca45c40334a79d2f6bbc9d538bb09a57eae3c53d7b4722304f25973873813d.png | simple | <table><tr><td>Variable</td><td>Mean</td><td>ICC</td><td>95% CI for ICC</td><td>Deff</td><td>n<sub>a</sub></td></tr><tr><td>Age (years)</td><td>26.1</td><td>0.018</td><td>0.004-0.033</td><td>5.3</td><td>265</td></tr><tr><td>Month stopped working</td><td>6.9</td><td>0.015</td><td><0.001-0.032</td><td>2.6</td><td>99</... |
70792b318ab5706d8df2f3e94e4257b2fbb3fb75d241663769cc0c686577f31f.png | simple | <table><tr><td>GroupNo.</td><td>Description</td><td>Body site where<i>S. aureus </i>detectedin Parsonnet 2005study<sup>a</sup></td><td>Ab present inParsonnet 2005study<sup>b</sup></td><td>No. of subjectsenrolled<sup>c</sup></td><td>No. of subjectscompleting allvisits</td></tr><tr><td>1</td><td>Carriers of SA TSST-1(+)<... |
673dec0b21cc7ac315cd3da224600e08ff223583df40be88762f7ab00012e1bf.png | complex | <table><tr><td colspan="8">Gay/Lesbian</td></tr><tr><td> </td><td colspan="2">Model 1 (adjusted for socio-demographic characteristics)<sup>a</sup></td><td colspan="2">Model 2 (controlling for depressive symptoms)<sup>b</sup></td><td>% reduction in association controlling for PHQ-9</td><td colspan="2">Sobel test for sig... |
d5ebf277e4faa67abbf435c4f6525af2d4a55f64080878158d8f341b8d83f75a.png | simple | <table><tr><td>Scenario</td><td>MP Windows (s)</td><td>PRN</td></tr><tr><td>1</td><td>8–16</td><td>27</td></tr><tr><td></td><td>21–25</td><td>11, 22</td></tr><tr><td></td><td>30–35</td><td>16</td></tr><tr><td></td><td>40–45</td><td>1, 4, 21, 27</td></tr><tr><td>2</td><td>20–80</td><td>1, 4... |
5a4b024750b9fce610dbaf6a474890cc0ff2a05968f5e4d1465750052563a8c8.png | simple | <table><tr><td></td><td>AUC</td><td>95%CI</td><td>z statistic</td><td><i>P</i> value (Area=0.5)</td><td>Associated criterion</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>With or without WBRT(0:no/1:yes)</td><td>0.650±0.0717</td><td>0.551-0.741</td><td>2.098</td><td>0.0359</td><td>>0</td><td>33.33</t... |
6f05a94c381dd0cfdf8b8123935eec690b4ed43e708282312049b94a10d071db.png | complex | <table><tr><td rowspan="2">Diagnostic Stage</td><td rowspan="2">Diagnostic Modality</td><td colspan="2">Sensitivity (%)</td></tr><tr><td>Central</td><td>Peripheral</td></tr><tr><td rowspan="10">Initial Diagnosis</td><td>Sputum cytology</td><td>71</td><td>49</td></tr><tr><td>Bronchoscopy</td><td>88</td><td>78</td></tr><... |
1f9aa3d2e47247b8d7b774cfd1c54a4aaf038d806d1599c3f36281a3047e3fbf.png | simple | <table><tr><td>MMP</td><td>ANOVA</td><td>Post Test Results</td></tr><tr><td>pMMP-9</td><td>p = 0.0817</td><td>No significant differences.</td></tr><tr><td>aMMP-9</td><td>p = 0.0944</td><td>No significant differences.</td></tr><tr><td>pMMP-2</td><td>p = 0.0010</td><td>pH 5.6 (24 h) < Positive Control (24 h) (p < 0... |
f6749a2da9a0448da1fc440b8d82cea0d5ba077e9c527aac82154b3ecbef0649.png | complex | <table><tr><td></td><td colspan="4">Health consumer</td></tr><tr><td>Health professional</td><td><i>Integration</i></td><td><i>Assimilation</i></td><td><i>Separation</i></td><td><i>Individualism (Marginalization)</i></td></tr><tr><td><i>Integration</i></td><td>Consensual</td><td>Problematic</td><td>Conflictual</td><td>... |
2a9ff13ea6f3ef91ac75a55ad3c4130285d9f954d149e6c677c8f26dd7aef60d.png | simple | <table><tr><td>Immuno-staining</td><td>DLBCL component positive</td><td>LP cells positive</td><td>Reduced expression in DLBCL component</td><td>Enhanced expression in DLBCL component</td><td>Identical expression in DLBCL and NLPHL component</td><td>Identical expression in DLBCL and NLPHL in simultaneous cases</td></tr>... |
7d6ca66862355d89a1912db9f80f3bfef5ad847c4b26cc7a9094bec087167f96.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">PCO</td></tr><tr><td>X</td><td>Y</td><td>Z</td></tr><tr><td>C31</td><td>−5</td><td>0</td><td>100</td></tr><tr><td>C32</td><td>−4.5</td><td>−30</td><td>250</td></tr><tr><td>C33</td><td>−20</td><td>0</td><td>150</td></tr><tr><td>C34</td><td>−20... |
70f0898f08d37724d9f40ddec206c85ce19eebff912614cc6ff5a48b6a4b7d4f.png | complex | <table><tr><td><i>Name</i></td><td><i>Position</i></td><td><i>Length</i></td><td><i>Orientation</i></td><td><i>Distance</i></td><td><i>Located on</i></td><td><i>Accession</i></td></tr><tr><td>001-G11-CCfw</td><td>70,072</td><td>669</td><td>fw</td><td rowspan="2">37,428</td><td>SSCR</td><td>FI107918</td></tr><tr><td>001... |
32dd7770578349911740cc667971d5db75c0383cce96e0b85a8b02a913419efe.png | complex | <table><tr><td>Variable</td><td>Value</td></tr><tr><td> Age (years)</td><td>63 (58–73)</td></tr><tr><td> Sex ratio (male/female)</td><td>16/9</td></tr><tr><td> Body mass index (kg/m<sup>2</sup>)</td><td>26 (22–27)</td></tr><tr><td> Euroscore 2 (%)</td><td>5 (3–8)</td></tr><tr><td> Left ventricular eje... |
84168a97ecdae2e0141631a0a87e25c54f3edeb5d8b00233d762f8e63b8c1c7b.png | complex | <table><tr><td> </td><td colspan="3">Prevention protocol</td><td colspan="3">Treatment protocol</td></tr><tr><td></td><td rowspan="2">DIO</td><td><i>L. laricina</i></td><td><i>L. laricina</i></td><td rowspan="2">DIO</td><td><i>L. laricina</i></td><td><i>L. laricina</i></td></tr><tr><td> </td><td>125 mg/kg</td><td>250 m... |
d0725a04fdbd6ae3eacaf69eb65d054decd07288d62b814b541c93465c0182f6.png | complex | <table><tr><td> </td><td> </td><td colspan="4">Classification accuracy(%)</td></tr><tr><td>Participant</td><td> </td><td>SELDA (M)</td><td>SELDA (C)</td><td>SEQDA(M)</td><td>SEQDA(C)</td></tr><tr><td>P1</td><td>AR</td><td>96.98</td><td>96.39</td><td>95.52</td><td>96.26</td></tr><tr><td> </td><td>FC</td><td>96.48</td><t... |
7837ed6c7c46f1b3d3a6bc2c227172d4c61ddab86c9cecb29264e6d9e54cd38c.png | complex | <table><tr><td></td><td></td><td></td><td>F25</td><td>F57</td><td>Ethanol × Fish Oil</td></tr><tr><td rowspan="2">Final body weight (g)</td><td>C</td><td>425.2 ± 4.4 <sup>c</sup></td><td>440.2 ± 4.7 <sup>a</sup></td><td>437.0 ± 10.7 <sup>b</sup></td><td>0.74</td></tr><tr><td>E</td><td>392.0 ± 1... |
e113f4dab9bbab281edc81379398b9a939078976090128989eeb225a8c579c6a.png | complex | <table><tr><td>Substance name</td><td>Mechanism of action</td><td>Clinical trial, design and results</td><td>Reference</td></tr><tr><td>TAK-242 (Resatorvid)</td><td>Binds covalently to Cys747 of TLR4-TIR domain and blocks TLR4/TIRAP and TLR4/TRAM interactions</td><td>Randomized, double-blind, placebo-controlled phase 2... |
60072c273ce961c402b8dbf86d7c3b5605e235a1e4b76cb8e5a979b899b8b642.png | complex | <table><tr><td> </td><td> </td><td>P-value</td><td>Lower 95% CI</td><td>Upper 95% CI</td></tr><tr><td rowspan="2">2hPG</td><td>Crude</td><td><.001</td><td>8.553</td><td>9.238</td></tr><tr><td>Adjusted</td><td><.001</td><td>8.546</td><td>9.241</td></tr><tr><td>FPG</td><td>Crude</td><td><.001</td><td>6.164</td><... |
d86626aaf2af8dfd016eacf9c179d4c4da2dcfd084b3b397e99b972a0d920c43.png | simple | <table><tr><td></td><td>All patients</td><td>Patients with OS >50 months</td><td>Patients with OS <50 months</td><td><i>P</i>value</td></tr><tr><td>ORR (%)*</td><td>44.9</td><td>82.6</td><td>17.9</td><td><0.00001</td></tr><tr><td>CBR (%)*</td><td>63.3</td><td>100</td><td>35.7</td><td><0.00001</td></tr><tr><... |
9dbbc55f9bfee07f6786a346d8cebc136822cd9791d34f770890dda9823e40aa.png | complex | <table><tr><td> </td><td>PD (<i>n</i> = 14)</td><td>CON (<i>n</i> = 17)</td><td rowspan="2"><i>P</i> value</td></tr><tr><td> </td><td>Means ± SD</td><td>Means ± SD</td></tr><tr><td>Age (years)</td><td>62.79 ± 4.59</td><td>61.35 ± 4.27</td><td>0.376 </td></tr><tr><td>Gender<sup>*</sup></td><td>11 M/3... |
c802de7c14b49674ed7ec8557157108f54fdcf418738582df6a94d69be94f1da.png | simple | <table><tr><td>Age group</td><td>Cyano.</td><td>N</td><td>Expo. to RBC (%)</td><td>RBC in CPB (%)</td><td>Expo. to FFP (%)</td><td>FFP in CPB (%)</td><td>Expo. to PLT (%)</td></tr><tr><td>< 1 mo.</td><td>1</td><td>8</td><td>6 (75)</td><td>4 (50)</td><td>2 (25)</td><td>8 (100)</td><td>0 (0)</td></tr><tr><td> </td><td... |
6edc9b8d31fd8dbb4ac4569e8cfee1edf6c89a9e13c1771592634540284ddf62.png | complex | <table><tr><td></td><td colspan="2">SERPINB9</td><td colspan="2">CD83</td><td colspan="2">CD9</td></tr><tr><td></td><td>Pool</td><td>Indiv</td><td>Pool</td><td>Indiv</td><td>Pool</td><td>Indiv</td></tr><tr><td>Control</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>MS</td><td>0.5</td><td>2.... |
bedadce8e2ed93b962016a8ed5f048c6662da5b225d0553c8ac5102b227b3e02.png | simple | <table><tr><td>QoL Domains</td><td>Mesor</td><td>Amplitude</td><td>Circadian Quotient</td><td>Rhythm Quotient</td><td>24-hr Correlation</td><td>Night-day Sleep Balance</td></tr><tr><td>EORTC Symptom Items</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Fatigue</td><td></td><td></td><td>-0.4</td><... |
a3b3504201f2c87484c7af2870c19383b9d6051128aee5cd91cc654fd3bd8903.png | simple | <table><tr><td>Case</td><td>Signs/symptoms</td><td>Treatment</td><td>R</td></tr><tr><td>1</td><td>Anorexia, weight loss, fasting hypoglycemia, and mental aberrations</td><td>IVH, Di</td><td>[12]</td></tr><tr><td>2</td><td>Weakness, anorexia, orthostatic dizziness, failure to lactate, and weight loss</td><td>BB, C</td><... |
43c2813198eb0aa32bb80a89b7f63804a3779310c1fd3af516beec5cea0f270f.png | simple | <table><tr><td></td><td>miR-96 (per million)</td><td>miR-182 (per million)</td><td>miR-183 (per million)</td></tr><tr><td>HER2-enriched (n = 34)</td><td>55.0 ± 46.9<sup>*</sup></td><td>49308.2 ± 31807.6</td><td>24494.0 ± 16871.2<sup>*</sup></td></tr><tr><td>Basal (n = 105)</td><td>42.3 ± 30.6</td><t... |
de1cd4fddc6e9d3caa6e5dff867ea01a200d27548501acbbad0cc5cd8af945c8.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Community-based organization Naloxone distribution</td><td rowspan="2">Traditional prescription</td><td colspan="4">Pharmacy-based Naloxone models</td></tr><tr><td>CPA</td><td>Standing medication order</td><td>Protocol order</td><td>Pharmacist prescribing</td></tr><tr><td... |
bfa7941d50b2bfa09ea59019bf9e49dda7cb4b5e469bb417b9350a07c59a8cbd.png | complex | <table><tr><td rowspan="2">Group (<i>n</i>)</td><td rowspan="2">M/F,<i>n</i>(missing data)</td><td rowspan="2">Age at death, yr (mean ± SD)</td><td colspan="3">Sections available,<i>n</i></td></tr><tr><td>Frontal</td><td>Temporal</td><td>Hippocampal</td></tr><tr><td>Controls (32)</td><td>14/18</td><td>72.0 ± ... |
ba3fe273bf307ea927487572b943005ab1e0705346494847a687ff7b20062341.png | simple | <table><tr><td></td><td>Patients<i>n</i></td><td>Tested forvitamin Dlevels (%)</td><td>Deficientor severelydeficient<sup>a</sup> (%)</td><td>Minimum level ofvitamin D for bonehealth<sup>b</sup> (%)</td><td>Vitamin D at> 75 nmol/L</td></tr><tr><td>Male</td><td>14</td><td>8 (57)</td><td>6 (75)</td><td>2 (25)</td><td>0... |
b61b3f7ba9c10d05749fb9ac3ce96b9d1a86e74e9623587997bd15d5fde4523c.png | simple | <table><tr><td>Term</td><td>Count</td><td><i>P</i>-value</td><td>Genes</td></tr><tr><td>Regulation of transcription, DNA-dependent</td><td>105</td><td>4.82E–06</td><td><i>REST, RORA, ZNF254, HOXC6, TDGF3, GATA6, TDGF1, OLIG2, MLL3, PITX2, NODAL, EMX2, ZNF814, EOMES, SUZ12, HES5, SOX7, LIN28A, NR2C2, ARX, FOXH1, L... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.